SYNTERACTHCR SWEDEN AB
Lukket 24. februar 2024
Nøgleord
researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors
Organisation
- Adm. direktør
- MS
- Driftstid
- 4 år
- - 5. dec. 2020 til 24. feb. 2024
- Type
- Norwegian division of foreign business enterprise
- Momsregistreret
- Nej
- Antal medarbejdere
- 0
Sidst opdateret: 2. jan. 2024
Ledelse
Ledelse / administration
| Navn | Rolle | Aktier |
|---|---|---|
MS | Managing Director/CEO | - |
Bestyrelse
| Navn | Rolle | Aktier |
|---|---|---|
S Lukket | Information about the Company in the Home Country | - |
Andre
| Navn | Rolle | Aktier |
|---|---|---|
| Accountant | - |
Sidst opdateret: 13. apr. 2023
Ejerandel
Ingen tilgængelige data
Økonomi
i NOK
Ingen tilgængelige data
Klassifikation
21st virksomhedsklassifikation
BETA
Lille virksomhed
Organisationstype
Norwegian division of foreign business enterprise
Standard for brancheklassifikation
M
Primært industriområde
Professional, scientific and technical activities
72
Aktivitet
Scientific research and development
72.1
Primær industrigruppe
Research and experimental development on natural sciences and engineering
72.11
Industrigruppe
Research and experimental development on biotechnology
72.110
Industrigruppe
Research and experimental development on biotechnology